(Q51034915)

27 March 2018

title

Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries. (English)

1 reference

27 March 2018

1 reference

Jaco Kraan

4

0 references

author name string

Wilfried H B M Levering

1

1 reference

27 March 2018

Frank W M B Preijers

2

1 reference

27 March 2018

Wessel N van Wieringen

3

1 reference

27 March 2018

Wil A M van Beers

5

1 reference

27 March 2018

Kees Sintnicolaas

6

1 reference

27 March 2018

Dick J van Rhenen

7

1 reference

27 March 2018

Jan W Gratama

8

1 reference

27 March 2018

publication date

1 May 2007

1 reference

27 March 2018

Cytometry Part B: Clinical Cytometry

published in

1 reference

27 March 2018

volume

72

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

178-188

1 reference

27 March 2018

Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

The CD34 Antigen: Structure, Biology, and Potential Clinical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Supralethal whole body irradiation and isologous marrow transplantation in man.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Stem cell mobilization.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Peripheral blood CD34+ cell count reliably predicts autograft yield

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

The whys and hows of hematopoietic progenitor and stem cell mobilization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA).

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

CD34 enumeration in a multicenter study. The AOR Stem Cell Group. American Oncology Resources

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Quality assurance of stem cell enumeration by flow cytometry. Canadian QASE Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Toward standardization of CD34+ cell enumeration: an international study. Biomedial Excellence for Safer Transfusion Working Party.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Quality assurance of progenitor cell content of apheresis products: a comparison of clonogenic assays and CD34+ enumeration. The Canadian Apheresis Group and Canadian Bone Marrow.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Selective susceptibility of CD34-expressing cells to acquire flow cytometric features of apoptosis/necrosis on exposure to an ammonium chloride-based red blood cell lysing reagent

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Australasian CD34+ quality assurance program and rationale for the clinical utility of the single-platform method for CD34+ cell enumeration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20351

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20351

1 reference

27 March 2018

1 reference

27 March 2018